SYP and Parkinson disease: Given that the synaptic dysfunction in Parkinson’s disease is likely associated with vulnerability of human dopaminergic terminals, further resulting in abnormal dopamine metabolism and depletion in dopamine neurotransmission, this finding is in alignment with the human condition, particularly given our observation in human tissue of loss of synaptophysin in striatum.